Man Group
MDGL icon

Man Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Man Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,764
Closed -$8.6M – 2503
2025
Q4 		$8.6M Sell
14,764
-6,564
-31% -$3.35M 0.01% 866
2025
Q3 		$9.78M Buy
21,328
+19,961
+1,460% +$7.45M 0.02% 802
2025
Q2 		$414K Buy
+1,367
New +$407K ﹤0.01% 1887
2025
Q1 		– Sell
-8,498
Closed -$2.62M – 2292
2024
Q4 		$2.62M Buy
+8,498
New +$2.39M 0.01% 1236
2023
Q3 		– Sell
-19,281
Closed -$3.63M – 1035
2023
Q2 		$4.45M Buy
+19,281
New +$5.22M 0.01% 919
2022
Q4 		– Sell
-7,600
Closed -$494K – 2116
2022
Q3 		$494K Buy
+7,600
New +$528K ﹤0.01% 1523
2022
Q1 		– Sell
-18,700
Closed -$1.58M – 2284
2021
Q4 		$1.58M Hold
18,700
– – 0.01% 1228
2021
Q3 		$1.49M Hold
18,700
– – 0.01% 1252
2021
Q2 		$1.82M Buy
18,700
+4,600
+33% +$545K 0.01% 1247
2021
Q1 		$1.65M Buy
+14,100
New +$1.64M 0.01% 1167
2019
Q2 		– Sell
-31,848
Closed -$3.99M – 1952
2019
Q1 		$3.99M Sell
31,848
-29,208
-48% -$3.63M 0.02% 1035
2018
Q4 		$6.88M Buy
61,056
+27,934
+84% +$4.32M 0.03% 608
2018
Q3 		$7.09M Buy
33,122
+11,503
+53% +$2.89M 0.03% 803
2018
Q2 		$6.05M Buy
+21,619
New +$3.8M 0.02% 843

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Man Group's MDGL Position: Q1 2026 in Review

Man Group sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2026, closing a stake of 14,764 shares — an estimated $8.6M sold.

Man Group first reported a position in MDGL in Q2 2018 and held it in 14 quarters. The position peaked at $9.78M in Q3 2025. 380 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Man Group reported no remaining Madrigal Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Man Group sold 14,764 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $8.6M.
  • Man Group first reported a position in Madrigal Pharmaceuticals in Q2 2018 and held it in 14 quarters.
  • Man Group's Madrigal Pharmaceuticals position peaked at $9.78M in Q3 2025.
  • 380 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.